PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

60 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... 3 ... ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
41.
Schütt, M.* et al.: Gender-specific effects of treatment with lifestyle, metformin or sulfonylurea on glycemic control and body weight: A German multicenter analysis on 9108 patients. Exp. Clin. Endocrinol. Diabet. 65, 622-626 (2015)
42.
Beck, I.* ; Schmidt-Weber, C.B. ; Eyerich, K.* ; Chen, W.* & Traidl-Hoffmann, C.*: Immune modulatory effects of sex hormones and leptin on monocytes and CD4+T cells. Exp. Clin. Endocrinol. Diabet. 122:P058 (2014)
43.
Berti, L. et al.: FGF21 inhibits adiponectin secretion in human adipocytes. Exp. Clin. Endocrinol. Diabet. 122:OP4_11 (2014)
44.
Gancheva, S.* et al.: Acute effects of intranasal insulin on endogenous glucose production and hepatic energy metabolism in humans. Exp. Clin. Endocrinol. Diabet. 122:P163 (2014)
45.
Kaiser, G. ; Gerst, F. ; Stefan, N. ; Ullrich, S. & Häring, H.-U.: The hepatokine fetuin-A associates with insulin resistance and induces inflammation but selectively improves cAMP-dependent insulin secretion of human islets. Exp. Clin. Endocrinol. Diabet. 122:OP4_13 (2014)
46.
Kruse, M.* et al.: A high-fat diet during pregnancy and lactation targets GIP-regulated metabolic pathways in male offspring in mice. Exp. Clin. Endocrinol. Diabet. 122:P012 (2014)
47.
Mühlhaus, J.* et al.: Aspects of 3-iodothyronamine (3T1AM) induced signaling by human and mouse trace amine-associated receptor 5 (TAAR5). Exp. Clin. Endocrinol. Diabet. 122:OP7_38 (2014)
48.
Peter, A. et al.: The I148 M variant in PNPLA3 is associated with altered hepatic lipid composition in humans. Exp. Clin. Endocrinol. Diabet. 122:P059 (2014)
49.
Riester, A.* et al.: Prevalence and clinical correlates of CACNA1D mutations in primary aldosteronism. Exp. Clin. Endocrinol. Diabet. 122:OP5_20 (2014)
50.
Wolf, S.* et al.: CNS impact of the GLP-1-Estrogen conjugate on food-motivated behavior. Exp. Clin. Endocrinol. Diabet. 122:P139 (2014)
51.
Claessen, H.* et al.: Medication costs by glucose tolerance stage in younger and older women and men: Results from the population-based KORA survey in Germany. Exp. Clin. Endocrinol. Diabet. 121, 614-623 (2013)
52.
Nagel, J.M.* et al.: Less advanced stages of colon cancer in patients with type 2 diabetes mellitus: An unexpected finding? Exp. Clin. Endocrinol. Diabet. 120, 224-228 (2012)
53.
Lederbogen, F.* et al.: Flattened circadian cortisol rhythm in type 2 diabetes. Exp. Clin. Endocrinol. Diabet. 119, 573-575 (2011)
54.
Kempf, K.* et al.: Vaspin (SERPINA12) genotypes and risk of type 2 diabetes: Results from the MONICA/KORA studies. Exp. Clin. Endocrinol. Diabet. 118, 184-189 (2010)
55.
Parhofer, K.G.* et al.: In Germany diabetic patients with coronary artery disease are treated more intensively than diabetic patients with other manifestations of atherothrombosis - results from the REACH registry. Exp. Clin. Endocrinol. Diabet. 118, 51-56 (2010)
56.
Schunk, M. et al.: Time trends in type 2 diabetes patients' disease management and outcomes: Evidence from two KORA surveys in Germany. Exp. Clin. Endocrinol. Diabet. 117, 88-94 (2009)
57.
Arnold-Wörner, N. ; Holle, R. ; Rathmann, W.* & Mielck, A.: The importance of specialist treatment, treatment satisfaction and diabetes education for the compliance of subjects with type 2 diabetes - results from a population-based survey. Exp. Clin. Endocrinol. Diabet. 116, 123-128 (2008)
58.
Mielck, A. ; Reitmeir, P. & Rathmann, W.*: Knowledge about diabetes and participation in diabetes training courses : The need for improving health care for diabetes patients with low SES. Exp. Clin. Endocrinol. Diabet. 114, 240-248 (2006)
59.
Ziegler, D.* et al.: Selective contribution of diabetes and other cardiovascular risk factors to cardiac autonomic dysfunction in the general population. Exp. Clin. Endocrinol. Diabet. 114, 153-159 (2006)
60.
Cooper, D.R. et al.: P-88: Insulin-induced changes in alternative splicing of MRNA: A mechanism for enhancing insulin responsiveness. Exp. Clin. Endocrinol. Diabet. 104, 149-150 (1996)
▮◀ ◀◀ 1 ... 2 ... 3 ... ▶▶ ▶▮